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Abstract
Hyperphosphorylation of RPA2 at serine 4 and serine 8 (S4, S8) has been used as a marker for activation of the DNA damage
response. What types of DNA lesions cause RPA2 hyperphosphorylation, which kinase(s) are responsible for them, and what
is the biological outcome of these phosphorylations, however, have not been fully investigated. In this study we
demonstrate that RPA2 hyperphosphorylation occurs primarily in response to genotoxic stresses that cause high levels of
DNA double-strand breaks (DSBs) and that the DNA-dependent protein kinase complex (DNA-PK) is responsible for the
modifications in vivo. Alteration of S4, S8 of RPA2 to alanines, which prevent phosphorylations at these sites, caused
increased mitotic entry with concomitant increases in RAD51 foci and homologous recombination. Taken together, our
results demonstrate that RPA2 hyperphosphorylation by DNA-PK in response to DSBs blocks unscheduled homologous
recombination and delays mitotic entry. This pathway thus permits cells to repair DNA damage properly and increase cell
viability.
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Introduction
Dividing cells have a higher risk of mutagenesis or death when
DNA replication is impeded by exposure to various stresses such
as UV or ionizing irradiations and toxic chemicals as well as
endogenous cellular byproducts including reactive oxygen
species. In particular, unrepaired DNA damage becomes an
obstacle for the DNA replication machinery and stalls the
progression of DNA replication forks. Stalled DNA replication
forks induce checkpoint activation by exposing significant
amounts of single-stranded DNA (ssDNA) coated by replication
protein A (RPA) due to the uncoupling of the helicase and the
DNA polymerases. RPA coated ssDNA recruits checkpoint
proteins such as ATR and the 9-1-1 complex (Rad9, Rad1,
Hus1) to promote checkpoint activation [1]. One of the most
important functions of the replication checkpoint is to stabilize
stalled replication forks [2]. Failure of stabilization of stalled
replication forks due to the inactivation of ATR or CHK1 leads
to forks collapse and exhibits high levels of DSBs [3,4]. These
DSBs could result in hyper-recombination that cause the
accumulation of mutations and genomic aberrations [5,6].
RPA is a heterotrimeric protein complex consisting of three
subunits, RPA1 (70 kDa), RPA2 (32 kDa), and RPA3 (14 kDa).
RPA2 is differentially phosphorylated during the cell cycle and
in response to DNA damage. S23 and S29 of RPA2 are
phosphorylated by cyclin dependent kinase (CDK) at the G1- to
S-phase transition, and then dephosphorylated at mitosis [7]. In
addition, at least 9 RPA2 sites (S4, S8, S11, S12, S13, T21, S23,
S29 and S33) are phosphorylated in a complex manner in
response to DNA damage and this is usually referred to as ‘‘RPA2
hyperphosphorylation’’ [8,9]. ATR, ATM, and DNA-PK have all
been implicated as the kinase(s) responsible for RPA2 hyperpho-
sphorylation [8,10,11,12,13,14,15,16,17]. However, it is still
poorly understood whether the hyperphosphorylated RPA2
represents the signal to checkpoint activation or DNA repair
and what is the biological function for RPA2 hyperphosphoryla-
tion.
Recent studies have demonstrated consequential phenotypes
when RPA2 hyperphosphorylation is blocked. Inhibition of RPA2
phosphorylation at T21 and S33 by ATR lead to a defect
in delaying DNA synthesis in response to UV damage [10].
Mutations at S23 and S29 in RPA2 caused an abnormal cell cycle
distribution both with and without DNA damage [18]. Addition-
ally, these mutations caused persistent staining of cH2AX
following DNA damage, suggesting that phosphorylation of
RPA2 at S23 and S29 facilitates DNA repair. Interestingly,
mutations at S23 and S29 in RPA2 also delayed mitotic exit into
G1 phase which was accompanied by a high level of apoptosis in
response to bleomycin treatment [18].
Compared to T21, S23, S29, and S33, the residues S4 and S8 of
RPA2 have not been studied in as much depth although
phosphorylation at these two sites has been used as a marker for
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21424the activation of the genotoxic checkpoint due mostly to the
logistical availability of an antibody specifically recognizing RPA2
phosphorylated at S4, S8 [19]. Here, we demonstrate that DNA
DSBs produced from stalled DNA replication induce S4, S8
phosphorylation in RPA2. Importantly, we also found that DNA-
PK, but not ATR or ATM, is the kinase that phosphorylates S4,
S8 in RPA2 in vivo. RPA2 hyperphosphorylated at S4, S8 delays
mitotic entry and appears to prevent unscheduled homologous
recombination at collapsed DNA replication forks.
Results
RPA2 hyperphosphorylation is induced by DNA damage
associated with stalled DNA replication
Previously, we demonstrated that stalled DNA replication
induces PCNA ubiquitination [20]. Since RPA accumulates at
stalled replication forks [21], we hypothesized that it could be also
modified in response to stalled replication. DNA damaging agents,
such as hydroxyurea (HU), methyl methane sulfonate (MMS), 4-
nitroquinoline 1-oxide (4NQO), camptothecin (CPT), and UV
irradiation can cause various DNA damage such as DNA
alkylation, DSBs, and DNA crosslinks, and stalled DNA
replication forks. HEK293T cells were treated with these DNA
damaging agents for 4 hours and the phosphorylation status of
RPA2 was subsequently monitored from the chromatin-bound
fraction of cell extract. In the UV and c-irradiation cases, treated
cells were allowed to recover for 4 hours and RPA2 phosphor-
ylation was monitored. Similar to PCNA ubiquitination, the
phosphorylation of RPA2 was induced in response to HU, MMS,
or HU, 4NQO, or CPT treatments, but not to c-irradiation. Two
slower migrating RPA2 bands (marked H for ‘‘hyperphosphory-
lated’’ and M for ‘‘intermediate’’) compared to unmodified RPA2
(marked B for ‘‘basal’’) were detected by Western blotting after
these treatments. The slowly migrating forms of RPA2 were due to
phosphorylation, because treatment of the extracts with l-
phosphatase before gel electrophoresis eliminated these forms
(Fig. 1B). Importantly, RPA2 phosphorylated at S4, S8 was
exclusively observed in the H form, but not in the M form
(Fig. 1A). Thus, RPA2 hyperphosphorylation can be marked by
the specific antibody against S4, S8 phosphorylation of RPA2. We
used this specific antibody to detect RPA2 hyperphosphorylation
thereafter. Ten Gy of c-irradiation, a level that is known to cause
DSBs without stalling replication did not induce RPA2 phosphor-
ylation when RPA2 phosphorylation was measured 4 hours post-
treatment (Fig. 1A). Our results suggest that RPA2 hyperpho-
sphorylation was induced by DNA damage resulting in stalled
DNA replication. Interestingly, stalled replication induced by UV,
MMS, HU, 4NQO, or CPT causes much stronger intensity of the
phosphorylation of H2AX (cH2AX) that marks DNA DSBs than
by g-irradiation (Fig. 1A).
RPA2 hyperphosphorylation depends on CDKs
CDK-dependent phosphorylation of RPA2 at S23, S29
(Figure 1A, M form of RPA2) occurs during DNA replication
[19,22,23,24]. To test if RPA2 hyperphosphorylation (Figure 1A,
H form) depends on CDKs, HEK293T cells were treated with a
CDK inhibitor, roscovitine for one hour to block CDK activities
before UV irradiation. Treatment of roscovitine prior to UV
irradiation inhibited RPA2 hyperphosphorylation in a dose-
dependent manner (Fig. 1C). Therefore, RPA2 hyperphosphor-
ylation in response to UV damage requires the activity of CDKs.
Consistently, RPA2 hyperphosphorylation decreases when cells
senesce or cells are in a non-dividing status [25].
DNA-PK hyperphosphorylates RPA2 in vivo in response
to UV or 4NQO
Previous studies have implicated various PIKKs responsible for
RPA2 hyperphosphorylation, including ATR [10,11], ATM
[15,16] and DNA-PK [8,12,13]. However, the results of these
studies were inconclusive in part because various types of DNA
damage were investigated, the methods used in these studies to
inhibit each PIKK were not very specific, and the phosphorylation
sites of different RPA2 molecules could not be monitored
specifically. Since the RPA2 hyperphosphorylation was specifically
induced by DNA damage stalling DNA replication (Fig. 1A) and
an antibody specifically recognizing S4, S8 phosphorylation of
RPA2 was available, we investigated which PIKK(s) was
responsible for RPA2 hyperphosphorylation.
Figure 1. DNA damage that results in DNA replication stalling induces H2AX and RPA2 phosphorylation. (A) Treatment of either 60 J/m
2
UV irradiation, 0.5 mM hydroxyurea (HU), 2.8 mM camptothecin (CPT), 0.01% methyl methane sulfonate (MMS), or 50 mM 4-nitroquinoline 1-oxide (4NQO) in
human HEK293T cells caused H2AX phosphorylation (cH2AX) and RPA2 hyperphosphorylation, whereas 5 Gy of c-irradiation did not. Cells were treated with
the indicated damaging agents for four hours before harvest. (B) Slowly migrating forms of RPA2 are due to phosphorylation. Treatment with l-phosphatase
reduced the slowly migrating forms of RPA2 to the migration position of the unmodified form. (C) Treatment with 50 mM or 200 mM roscovitine for one hour
before 60 J/m
2 UV irradiation in HEK293T cells suppressed RPA2 hyperphosphorylation. Hyperphosphorylation, intermediate phosphorylation, and no
p h o s p h o r y l a t i o no fR P A 2a r ei n d i c a t e da sH ,M ,a n dB ,r e s p e c t i v e l y .
doi:10.1371/journal.pone.0021424.g001
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(DNA-PKcs), TEL2 or CHK1 was silenced by siRNA (Fig. 2A).
Silencing of each gene expression was confirmed by Western blot
analysis and qRT-PCR (Fig. 2A and data not shown). Silencing of
ATR or CHK1 expression was also verified using a phospho-
CHK1 (S345) antibody to confirm the inability of CHK1 to be
activated in response to UV (Fig. 2A). As expected, ATM, DNA-
PKcs, or TEL2 silencing compromised CHK2 activation phospho-
CHK2 (T68) in response to UV (Fig. 2A). Importantly, silencing of
DNA-PKcs or TEL2 expression almost eliminated the UV-
induced phosphorylation at S4, S8 in RPA2 (Fig. 2A, marked
H). TEL2 silencing reduced the expression of both ATM and
DNA-PKcs (Fig. 2A). Since the depletion of ATM did not cause
any reduction in S4, S8 phosphorylation of RPA2 (Fig. 2A,
marked H), the reduced S4, S8 phosphorylation of RPA2 by
TEL2 silencing appeared to result from the down-regulation of
DNA-PKcs.
To further investigate the dependency of RPA2 hyperpho-
sphorylation on DNA-PK, RPA2 hyperphosphorylation was
examined after silencing the expression of the DNA heterodimeric
Ku86:Ku70 DNA binding subunit of DNA-PK. Similar to DNA-
PKcs or TEL2 silencing, Ku86 silencing by siRNA inhibited the
hyperphosphorylation of RPA2 in response to UV treatment
(Fig. 2B). Consistently, S4, S8 phosphorylation of RPA2 by DNA-
PK was observed in vitro [19].
DNA-PK dependent phosphorylation at S4, S8 in RPA2 in
response to UV treatment was investigated in the DNA-PKcs null
HCT116 cell line [26]. In contrast to the normal RPA2
hyperphosphorylation at S4, S8 observed in response to UV or
4NQO treatment in the parental HCT116 cells, RPA2 hyperpho-
sphorylation was completely eliminated in the HCT116 cell line
where the DNA-PKcs gene is disrupted by gene targeting (Fig. 2C
and D, H form of RPA2). Importantly, primed RPA2 phosphor-
ylated at S23 and S29, which is catalyzed by CDK [19] after UV
or 4NQO treatment and required for hyperphosphorylation at the
residues of S4 and S8 in RPA2, was detected in DNA-PKcs null
HCT116 cells (Fig. 2D, M form of RPA2). Similarly, the M059J
cell line that has defects in DNA-PKcs could not induce S4, S8
phosphorylation in response to 4NQO (Fig. 2E and F). In contrast,
hypomorphic ATR mutated Seckel cells or ATM null cells (AT)
still induced the S4, S8 phosphorylation of RPA2 similar to the
wild type in response to 4NQO treatment (Fig. 2G). Taken
together, these results strongly suggest that S4, S8 phosphorylation
of RPA2 depends on DNA-PK, but not on ATR or ATM.
The levels of DNA double-strand breaks correspond to
hyperphosphorylation of RPA2
cH2AX is induced by DNA DSBs [27] and was observed as a
consequence of the DNA damage treatments that enhanced RPA2
hyperphosphorylation (Fig. 1A). Therefore, we hypothesized that
the DNA damaging agents we had tested were generating DSBs
from the collapse of replication forks and such DSBs at forks are
substrates for DNA-PK. To explore this possibility, we monitored
the kinetics of RPA2 phosphorylation and DSB formation by
measuring cH2AX after 60 J/m
2 UV treatment (Fig. 3A). RPA2
phosphorylation was induced at approximately the same time as
when the level of cH2AX was induced. In addition, we measured
direct DSBs with a TUNEL assay (Fig. 3B). Similar to the kinetics
of cH2AX induction, we could observe DSB formation following
UV treatment. Lastly, we analyzed chromosomes from cells
treated with UV, HU, 4NQO, or CPT by pulsed field gel
electrophoresis. DSBs were markedly visible in cells treated with
UV, HU, 4NQO, or CPT with 2.6, 1.7, 9.9, and 3.6 fold more
DSBs than the mock treated sample (Fig. S1), which were the same
agents that induced RPA2 hyperphosphorylation (Fig. 1A).
Interestingly, when cells were treated with high dose of c-
irradiation (e.g. 40 Gy) that generates 2.3 fold more DSBs, we
observed the RPA2 hyperphosphorylation at 4 hours post-
treatment. This was not present in cells with 5 or 10 Gy of c-
irradiation treatment at 4 hours post-treatment (Fig. 1A and S2).
The level of DSB formation by 40 Gy of c-irradiation was
comparable to that of UV, HU, or CPT treatment where RPA2
hyperphosphorylation was observed. In addition, while 5 or 10 Gy
of c-irradiation did not generate enough DSBs to be detected by
pulsed field gel electrophoresis and triggered only a mild increase
of cH2AX at early time points following 5 or 10 Gy of c-
irradiation, RPA2 hyperphosphorylation as well as a higher level
of cH2AX occurred at later times (Fig. S2). Specifically, RPA2
hyperphosphorylation was highly induced at 24 hours post c-
irradiation (10 Gy) exposure. Since 10 Gy of c-irradiation did not
block ongoing DNA replication [20], unrepaired DSBs appear to
cause RPA2 hyperphosphorylation when they are processed by
resection to produce ssDNA. Therefore, the hyperphosphorylation
of RPA2 likely results from high levels of resected DSBs.
To investigate whether the hyperphosphorylated RPA2 localizes
to the sites of DSBs, cells were stained with antibodies specifically
recognizing phospho-S4, S8 RPA2 and cH2AX before and after
exposure to 60 J/m
2 of UV treatment. Without UV treatment,
there was only weak cH2AX and phospho-S4, S8 RPA2 staining
(Fig. 3C, upper panel). UV treatment markedly increased the
number of cells and the number of foci in the nuclei that positively
stained with a cH2AX antibody. Importantly, cells with elevated
cH2AX levels were also positively stained with an antibody
recognizing phospho-S4, S8 RPA2 (Fig. 3C, bottom panel) and the
foci stained by cH2AX co-localized with phospho-S4, S8 RPA2.
Since pulse-labeling cells with BrdU following UV irradiation
predominantly labels sites of stalled DNA replication [28], the
proteins that can be immunoprecipitated together with BrdU
represent proteins that are enriched at stalled DNA replication
forks. Since phospho-S4, S8 RPA2 and cH2AX co-immunopre-
cipitated with a BrdU antibody (Fig. 3D), we inferred that cH2AX
and phospho-S4, S8 RPA2 were indeed enriched at the stalled and
presumably collapsed replication forks. Taken together, our results
suggest that RPA2 hyperphosphorylation corresponds to the level
of DSBs generated in cells.
RPA2 hyperphosphorylation delays mitotic entry
Since RPA2 phosphorylation is regulated during the cell cycle
and presumably DNA damage should be repaired before entering
mitosis, S4, S8 phosphorylation of RPA2 induced by DNA
damage could regulate the progression of cell cycle. To examine
whether DNA-PK dependent S4, S8 phosphorylation of RPA2
affected the cell cycle, a site-specific RPA2 mutant with S4, S8
changed to alanine (S4A, S8A) was expressed in cells where the
endogenous RPA2 had been silenced by siRNA. RPA2 hyperpho-
sphorylation was not detected in the RPA2 S4A, S8A mutant,
most notably at S4 and S8 in response to treatment with 2 mM
hydroxyurea (HU) for 22 hours (Fig. S3A). In contrast, endoge-
nous RPA2 and wild type transfected RPA2 were hyperpho-
sphorylated by the same stress. Cells expressing exogenous wild
type RPA2 (WT-RPA2) or the RPA2 S4A, S8A mutant displayed
similar cell cycle profiles in the absence of DNA damaging agents
(Fig. S3B). When cells were pre-treated with 2 mM HU for
22 hours to induce the collapse of replication forks (Fig. 4A) and
then released into media containing 0.5 mg/ml of nocodazole to
inhibit cells from entering another cell cycle, the cells expressing
the RPA2 S4A, S8A mutant entered mitosis more frequently than
cells expressing the WT RPA2 (Fig. S3C). Independently, we
DNA-PK-Dependent RPA2 Phosphorylation
PLoS ONE | www.plosone.org 3 June 2011 | Volume 6 | Issue 6 | e21424Figure 2. DNA-PK phosphorylates residues S4, S8 in RPA2 in response to DNA damage. (A) RPA2 hyperphosphorylation induced by UV
irradiation is dependent on DNA-PK. Expression of ATR, ATM, DNA-PK, TEL2, or CHK1 were silenced by siRNA in HEK293T cells and RPA2
hyperphosphorylation in response to 60 J/m
2 UV irradiation was monitored. (B) RPA2 hyperphosphorylation is also dependent on the DNA binding
subunit of DNA-PK, Ku86. (C) DNA-PKcs-null HCT116 cells do not express DNA-PKcs. (D) DNA-PKcs-null (DNA-PK
2/2) HCT116 cells do not show RPA2
hyperphosphorylation in response to UV irradiation or 4NQO treatment compared to the parental HCT116 cells (DNA-PK
+/+). (E) DNA-PK
2/2 (MO59J)
cells do not express ATM and DNA-PK. (F) DNA-PK
2/2 (MO59J) cells do not show RPA2 hyperphosphorylation in response to 4NQO treatment
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PLoS ONE | www.plosone.org 4 June 2011 | Volume 6 | Issue 6 | e21424confirmed a higher frequency of cells expressing the RPA2 S4A
S8A mutant entering mitosis by counting cells positively stained
with phosphohistone H3. There was a significant increase in the
population entering mitosis when RPA2 S4A, S8A was expressed
after HU treatment; 4% of cells expressing RPA2 S4A, S8A versus
3% of cells expressing WT RPA2 (Fig. 4B and S3D; p,0.05).
Similarly, when DNA-PKcs was silenced by siRNA, a significantly
higher population entered mitosis (Fig. 4C and S3E; p,0.05).
Therefore, DNA-PK-dependent RPA2 phosphorylation at S4, S8
appeared to function in the G2/M checkpoint and caused the
delay of cells from entering mitosis with damaged DNA.
Consistently, cells expressing the RPA2 S4A, S8A mutant became
slightly more sensitive to the DNA damaging agent 4NQO,
presumably due to the high level of cell death resulting in cells
expressing this mutant protein that subsequently entered mitosis
with DNA damage (Fig. 4D). Therefore, at least one of the
outcomes of DNA-PK-dependent RPA2 hyperphosphorylation is
the delay of mitotic entry, which gives cells more time to repair
DNA damage properly.
RAD51 foci formation and UV-induced sister chromatid
exchange rate are increased by expression of the RPA2
S4A, S8A mutant
DSBs are often repaired by homologous recombination (HR).
HR is initiated by the replacement of RPA with the DNA strand
compared to a matched DNA-PK
+/+ (MO59K) cell line. (G) Lymphocytes defective in ATR (Seckel) or ATM (ATM
2/2) as well as wild type lymphocytes
produce RPA2 hyperphosphorylation in response to 4NQO treatment. Hyperphosphorylation, intermediate phosphorylation, and no phosphorylation
of RPA2 are indicated as H, M, and B, respectively. NC, non-targeting control siRNA.
doi:10.1371/journal.pone.0021424.g002
Figure 3. RPA2 hyperphosphorylations correspond to the level of DSBs. (A) Kinetics of RPA2 phsophorylation and cH2AX are similar after
UV treatment. HeLa cells were irradiated with 60 J/m
2 UV and S4, S8 phosphorylation of RPA2 and cH2AX were monitored. (B) DNA DSBs are
generated in a similar kinetics with RPA2 phosphorylation after UV treatment. DNA DSBs by TUNEL assay were measured after 60 J/m
2 UV irradiation
using In situ Cell Death Detection Kit (Roche). (C) S4, S8 phosphorylated RPA2 foci are co-localized with cH2AX foci in response to UV irradiation.
HEK293T cells were stained with specific anti-cH2AX or anti-phospho-RPA2 (S4, S8) (phospho-RPA2 (S4, S8)) antibodies after UV irradiation. (D) S4, S8
phosphorylated RPA2 and cH2AX are enriched at sites of stalled replication. Stalled replication forks that were pulse-labeled with BrdU were then
immunoprecipitated with an antibody recognizing BrdU after cross-linking. Proteins in the immunoprecipitate were examined with specific
antibodies as indicated.
doi:10.1371/journal.pone.0021424.g003
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was highly enriched in the chromatin fraction following treatments
with DNA damaging agents that caused the collapse of replication
forks (Fig. 1), it seemed possible that RPA2 hyperphosphorylation
could interfere with HR by affecting RAD51 filament formation.
To test this hypothesis, we examined RAD51 foci formation in
response to c-irradiation or HU treatments in cells expressing WT
RPA2 or RPA2 S4A, S8A. RAD51 foci formation was induced by
c-irradiation in both WT RPA2 and RPA2 S4A, S8A expressing
cells (Fig. 5A and S4). However, when the number of RAD51 foci
in individual cells was compared after irradiation, cells expressing
RPA2 S4A, S8A had a higher number of RAD51 foci compared
to cells expressing WT RPA2 (Fig. 5A). Consistently, the signal
intensities of RAD51 were brighter in cells expressing RPA2 S4A,
S8A compared to cells expressing WT RPA2 following HU
treatment for 24 hours (Fig. 5B). Therefore, blocking S4, S8
phosphorylation of RPA2 enhanced RAD51 foci formation.
The number and intensity of RAD51 foci are closely related
with HR frequency [29]. To investigate if the RPA2 S4A, S8A
mutation also affects HR frequency, especially in response to DNA
damage that results in stalled DNA replication, we measured sister
chromatid exchange (SCE) rate in cells treated with 10 J/m
2 UV
irradiation (Fig. 5C). There was a significant increase of SCE rate
in cells expressing the RPA2 S4A, S8A mutant protein
(p,0.0001). Taken together, the DNA-PK-dependent phosphor-
ylation of RPA2 at S4, S8 appears to block HR and this
phosphorylation needs to be removed such that RAD51 foci
formation can initiate HR.
Discussion
In the present study, we demonstrated that RPA2 hyperpho-
sphorylation at S4 and S8 was dependent on DNA-PK. DNA-PK
detects DNA DSBs with its DNA end-binding subunit Ku70-Ku80
heterodimer. Similarly, we found that DNA DSBs marked by
cH2AX elicited RPA2 hyperphosphorylation by DNA-PK. Higher
levels of DSBs generated stronger RPA2 hyperphosphorylation
(Fig. 3A). Importantly, DNA-PK-dependent RPA2 hyperpho-
sphorylation requires ‘‘primed’’ RPA2 phosphorylation in other
residues of RPA2 that depends on CDK activity. Suppression of
CDK activity by roscovitine, eliminates RPA2 hyperphosphoryla-
tion (Fig. 1C). Consistently, RPA2 hyperphosphorylation decreases
when cells senesce or are in a non-dividing status [25].
Previous studies have shown that ATR, ATM, or DNA-PK can
induce RPA2 hyperphosphorylation [10,15,16,30,31]. However,
our results are consistent with several groups that DNA-PK is the
Figure 4. S4, S8 phosphorylation in RPA2 delays mitotic entry and confers resistance to 4NQO. (A) Scheme for HU treatment. (B) RPA2
S4A S8A cells enter mitosis more frequently after release from HU treatment. More than 50,000 cells were counted for each cell type. The average
from three independent experiments with standard deviation is presented. (C) Silencing the expression of DNA-PKcs makes cells enter mitosis more
frequently after release from HU treatment. More than 50,000 cells were counted for each cell type. The average from three independent experiments
with standard deviation is reported. (D) Cells expressing the RPA2 S4A S8A mutant are more sensitive to 4NQO.
doi:10.1371/journal.pone.0021424.g004
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damage [8,12,14,17,19,32]. Interestingly, depletion of ATM or
ATR did not reduce RPA2 hyperphosphorylation; instead, it
enhanced RPA2 hyperphosphorylation. A high level of DSBs
generated in ATR- and ATM-defective cells appears to recruit
DNA-PK at DSBs to hyperphosphorylate RPA2.
RAD18-dependent post-replication repairs (PRRs) pathways
including translesion synthesis and template switching are DNA
damage tolerance pathways bypassing DNA damage that results in
stalled DNA replications [33]. Although RAD18-dependent PRR
does not remove actual DNA damage, it can prevent collapses of
stalled forks that can ultimately generate DSBs. Consistently, we
observed that RAD18 depletion increased the level of DSBs, as
indicated by the increases in both cH2AX and RPA2 hyperpho-
sphorylation (Fig. 2B). Therefore, prolonged stalling of DNA
replication due to defects in PRRs appears to result in collapse of
DNA replication forks to produce DSBs. Similarly, RPA2
hyperphosphorylation was enhanced in DNA polymerase g-
deficient human cells which cannot bypass UV-induced DNA
damage [34].
RPA2 hyperphosphorylation depends on DSBs resected to form
ssDNAs. In S phase, RPA2 is first primed by CDK-dependent
phosphorylation. The primed-phosphorylated RPA is constantly
loaded in DNA during DNA replication to cover ssDNA in the
lagging strand. Therefore, DSBs generated in S phase already
have primed-phosphorylated RPA. In addition, stalled DNA
replication forks resulting from DNA damage causes a high level of
ssDNA that is rapidly coated with primed-phosphorylated RPA2.
Therefore, RPA2 phosphorylation by DNA-PK could be achieved
rapidly at stalled replication forks that then collapse into DSBs. In
contrast, RPA2 hyperphosphorylation began to appear at 8 hours
after exposure to 10 Gy of c-irradiation (Fig. S2). This delayed
RPA2 hyperphosphorylation could be due to the required
resection of DSBs to produce ssDNA and loading of RPA with
primed-phosphorylated RPA2. Interestingly, an extremely high
dose of c-irradiation (40 Gy) could produce RPA2 hyperpho-
sphorylation in less than 4 hours post-irradiation (Fig. S2). It is
puzzling why high dose c-irradiation can elicit RPA2 hyperpho-
sphorylation in a short time given that primed-phosphorylations in
other resides of RPA2 catalyzed by CDK are required for RPA2
hyperphosphorylation. One possibility is that asynchronized
populations have enough cells in S phase that have an available
supply of primed-phosphorylated RPA2. This supply of primed
RPA2 could then be recruited to the numerous 40 Gy-induced
resected DSBs and RPA2 hyperphosphorylation could be
achieved in a short time. However, the fact that we could not
detect any primed-phosphorylated RPA2 in asynchronized cells
argues against this possibility. Alternatively, it is possible that
RPA2 hyperphosphorylation by c-irradiation could be different
Figure 5. S4, S8 phosphorylation of RPA2 inhibits homologous
recombination. (A) Cells expressing the RPA2-S4A S8A mutant protein
generate more RAD51 foci than cells expressing wild type (WT)-RPA2.
RAD51 foci were counted after cells were treated with 5 Gy of c-
irradiation with 6 hr of recovery. 275 cells of wild type (WT) and 323
cells of mutant (S4A, S8A) RPA2 were analyzed for RAD51 foci
formation. (B) Cells expressing the RPA2 S4A, S8A mutant express
more RAD51 than WT-RPA2 cells. RAD51 histograms were measured in
cells treated with HU for 22 hr or mock treated and allowed to recover
for 6 hr. Median numbers are provided. (C) The S4A, S8A mutations
cause an increase in the UV-induced SCE rate in HEK293T cells
(P,0.0001). Two independent experiments were performed and the
average percentage of SCE with standard deviation is reported. A total
66 WT-RPA2 and 89 RPA2 S4A, S8A metaphases cells were counted.
doi:10.1371/journal.pone.0021424.g005
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What is the outcome of RPA2 hyperphosphorylation by DNA-
PK? Our results suggest that RPA2 hyperphosphorylation might
delay mitotic entry to allow for completion of DNA repair.
Therefore, cells expressing the RPA2 S4A, S8A mutant protein
that cannot be hyperphosphorylated were sensitive to 4NQO
treatment (Fig. 4D). Interestingly, cells expressing the RPA2 S4A,
S8A mutant protein enhanced the formation of RAD51 foci,
indicating that HR was initiated (Fig. 5A, B). In further support of
this, there was a significant increase of SCE in cells expressing
RPA2-S4A S8A mutant protein (Fig. 5C). Similarly, HR was
suppressed by depletion of protein phosphatase 4, which increases
RPA2 hyperphosphorylation or by expression of the RPA2-D4
(S23D, S29D, S33D, S8D) mutant protein, which mimics RPA2
hyperphosphorylation [35]. Therefore, we speculate that DNA-
PK dependent RPA2 hyperphosphorylation during DNA replica-
tion might inhibit unscheduled HR initiation at collapsed forks.
We propose that DNA-PK is recruited to DSBs during DNA
replication and hyperphosphorylates RPA2 to give cells chance to
complete DNA repair before mitotic entry [9,10]. At the
molecular level, DNA-PK dependent RPA2 hyperphosphorylation
appears to suppress unscheduled HR that might lead to genomic
instabilities including translocations and genomic rearrangements.
Materials and Methods
Cell Culture, Reagents, and Antibodies
HEK293T cells were cultured in DMEM supplemented with
10% fetal bovine serum (FBS), and 2% glutamine. U2OS/DR-
GFP cells were grown in McCoy’s media supplemented with 10%
FBS. The antibodies used were anti-RPA2 (Calbiochem), anti-
phospho-RPA2 (S4, S8) (Bethyl Laboratories), anti-phospho-
RPA2 (S33) (Bethyl Laboratories), anti-ATR (Santa Cruz), anti-
ATM (Santa Cruz), anti-DNA-PKcs (Thermo Scientific), anti-
CHK1 (Santa Cruz), anti-CHK2 (Santa Cruz), anti-phospho-
CHK1 (Ser 345) (Cell signaling), anti-phospho-CHK2 (Thr 68)
(Cell signaling), anti-cH2AX (Upstate), anti-H2AX (Abcam), anti-
HA (HA-7, Sigma). The SMART pools of all gene-specific siRNAs
were purchased from Dharmacon. MMS, HU, 4NQO, campto-
thecin were purchased from Sigma.
Construction of Various Expression Plasmids
Both wild type RPA2 and the S4A S8A mutant RPA2 used in
this study contain an HA epitope tag. HA-RPA2 S4A, S8A was
generated by site-directed mutagenesis (Stratagene) with two
primers GAC CAA GAT GTG GAA CGC TGG ATT CGA
AGC CTA TGG CAG CTC CTC and GAG GAG CTG CCA
TAG GCT TCG CCA GCG TTC CAC ATC TTG GTC.
Detection of Chromatin-bound RPA2
HEK293T, MO59K, MO59J, HCT116 (a gift from Dr. Eric
Hendrickson’s laboratory, University of Minnesota), Seckel, or AT
cells (purchased from Coriell Institute) (as shown in Figure 1 and 3
respectively) were treated with DNA damaging agents for four
hours before the cells were harvested as indicated in figures. When
cells were treated with either IR or UV, cells recovered for four
hours after irradiation and were then harvested. To make the
chromatin-bound fraction, approximately 10
7 cultured cells were
resuspended in buffer A (10 mM HEPES (pH 7.9), 10 mM KCl,
1.5 mM MgCl2, 0.34 M Sucrose, 10% Glycerol, 1 mM PMSF,
5 mg/mL aprotinin, 20 mg/mL leupeptin) and Triton X-100 was
added (to a final concentration of 0.1%). Precipitated chromatin-
bound fractions obtained by centrifugation at 4uC at 1,3006g for
5 min were then resuspended in TSE500 buffer [20 mM Tris
(pH 8.1), 2 mM EDTA, 500 mM NaCl, 0.1% SDS, 1% Triton X-
100, protease inhibitor cocktail (Roche)] and sonicated. Chroma-
tin-bound proteins were collected from the supernatant after
centrifugation at 17,0006g for 5 min.
RAD51 Immunofluorescence Microscopy
10
5 HEK293T cells plated on two-well chamber slides were
transfected with siRNA specifically targeting the 39-UTR of RPA2
(Dharmacon, SMART pool, #9, #11, #12), together with a
plasmid expressing either siRNA-resistant HA-tagged RPA2 or
RPA2 S4A, S8A and cultured for three days. The cells were then
irradiated with 5 Gy of c-irradiation followed by a 6 hr recovery
period and then fixed with 3.5% paraformaldehyde for 15 min
and permeabilized with 1% Triton X-100 for 10 min. Fixed cells
were blocked with 5% FBS and stained with anti-RAD51 and
rhodamine-conjugated anti-mouse secondary antibodies.
Flow Cytometry Analyses
Two days post transfection (to allow cells to replace the
endogenous RPA2 in HEK 293T cells as described above), cells
were incubated with 2 mM of HU for 22 hr. Cells were then
cultured in fresh medium without HU but with 0.5 mg/ml of
nocodazole for 12 hr. BrdU was added at 1 hr before harvest.
Cells were then fixed and stained with both APC-conjugated
anti-BrdU and FITC-conjugated anti-phospho-H3 antibodies.
Cells were sorted by Becton Dickinson FACSCaliburs as
described [20].
siRNA and Recombination Reporter Assay
U2OS human osteosarcoma cell lines stably transfected with a
single copy of an intact DR-GFP reporter gene were used to
measure the HR frequency [36]. The endogenous RPA2 was
replaced with HA-tagged RPA2 or RPA2 S4A, S8A as described
above. Two days later, a plasmid pCAG-I-SceI (which expresses I-
SceI enzyme), or an empty vector, pCAG, together with a pDsRed
monomer (as a transfection efficiency control) were transfected.
HR frequency was determined by the number of cells expressing
GFP divided by the number of cells expressing DsRed monomer.
Experiments were repeated at least three times and the average
values are reported.
Pulsed field Gel Electrophoresis
,2.5610
6 of HEK293T cells were treated with DNA damaging
agents for 4 hr. Cells were then trypsinized and melted into
SeaPlaque GTG agarose (Cambrex Bio Science Rockland, Inc)
with 0.75% agarose final concentration. Agarose plugs were then
digested in proteinase K reaction buffer (100 mM EDTA, pH 8.0,
0.2% sodium deoxycholate, 1% sodium lauryl sarcosine, and
1 mg/ml Proteinase K) at 50uC for 2 days and washed 4 times in
wash buffer (20 mM Tris, pH 8.0, 50 mM EDTA). The plugs
were loaded onto a 1% pulsed field certified agarose (Biorad).
Separation was performed on a CHEF-DR III pulsed field
electrophoresis systems (Biorad; 120 field angle, 240 s switch time,
4 V/cm, 14uC) for 24 hr. Gels were stained with ethidium
bromide and DSBs were quantified and analyzed using fluores-
cence image analyzing system FLA 5100 (FujiFilm).
Cell Survival Assay
Cell viability was determined in HEK293T cells where
endogenous RPA2 was replaced by WT-RPA2 or RPA2 S4A,
S8A. Approximately 6000 cells were plated in triplicate on 96-well
plates. 4NQO was added into the medium16 hr after plating. Cell
DNA-PK-Dependent RPA2 Phosphorylation
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proliferation assay kit (Invitrogen).
Supporting Information
Figure S1 DNA damaging agents that stall DNA repli-
cation cause high level of DSBs. Chromosomal DNAs
isolated from HEK293T cells treated with various DNA
damaging agents were separated by pulse-field gel electrophore-
sis. The levels of DSBs were normalized to that in the no
treatment lane (mock).
(TIF)
Figure S2 DSBs as well as RPA2 hyperphosphorylation
were increased when cells were incubated after treat-
ment of c-irradiation. Chromatin-bound fractions from
HEK293T cells irradiated with the indicated doses of c-irradiation
were prepared at different time points (10 Gy) or four hours after
irraditation (40 Gy) and phosphorylation of H2AX (cH2AX) and
RPA2 hyperphosphorylation were examined. Hyperphosphoryla-
tion, intermediate phosphorylation, and no phosphorylation of
RPA2 are indicated as H, M, and B, respectively.
(TIF)
Figire S3 S4A S8A mutations in RPA2 cause higher
frequency of mitotic entry. (A) RPA2 S4A, S8A mutant is not
hyperphosphorylated in response to DNA damage. Cells were
treated with HU in condition described in ‘‘C’’. B1 and B2 are
unmodified endogenous and transfected HA-tagged RPA2,
respectively. H1 and H2 are hyperphosphorylated endogenous
and transfected HA-tagged RPA2, respectively. (B) Cells express-
ing either wild type RPA2 or S4A S8A mutant RPA2 (S4A S8A)
did not show any distinct differences in cell cycle profiles. (C) Cells
expressing S4A S8A mutatant RPA2 entered mitosis more
frequently after release from DNA replication stress by HU. Cells
were treated with HU for 22 hours and washed to release into
media having Nocodazol without HU to inhibit another round of
cell cycle. After 11 hours incubation, cells were pulse-labeled with
BrdU for one hour before FACS analysis. (D) Mitotic cells positive
in both BrdU and Phospho H3 were increased in cells expressing
S4A S8A RPA2 mutant. (E) Silencing the expression of DNA-
PKcs increased mitotic cells that were positive in both BrdU and
Phospho H3.
(TIF)
Figure S4 S4A S8A mutations in RPA2 increased the
number of RAD51 foci in response to 10 Gy c-irradia-
tion.
(TIF)
Acknowledgments
We thank Drs. E. Hendrickson (U. Minnesota), M. Jasin (Sloan Kettering
Memorial Institute), and X. Wu (The Scripps Research Institute) for
plasmids and cells; S. Anderson for FACS analysis. Drs. B. Chen
(Southwestern Medical Center), E. Hendrickson, X. Wu and members in
Myung laboratory for comments on the manuscript; and J. Fekecs
(NHGRI) for figure preparation. K.M. especially thanks E. Cho.
Author Contributions
Conceived and designed the experiments: HL DL KM. Performed the
experiments: HL DL. Analyzed the data: HL DL KM. Contributed
reagents/materials/analysis tools: HL KM. Wrote the paper: HL KM.
References
1. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S (2004) Molecular
mechanisms of mammalian DNA repair and the DNA damage checkpoints.
Annu Rev Biochem 73: 39–85.
2. Sogo JM, Lopes M, Foiani M (2002) Fork reversal and ssDNA accumulation at
stalled replication forks owing to checkpoint defects. Science 297: 599–602.
3. Syljuasen RG, Sorensen CS, Hansen LT, Fugger K, Lundin C, et al. (2005)
Inhibition of human Chk1 causes increased initiation of DNA replication,
phosphorylationofATRtargets, and DNAbreakage.MolCellBiol 25: 3553–3562.
4. Brown EJ, Baltimore D (2003) Essential and dispensable roles of ATR in cell
cycle arrest and genome maintenance. Genes Dev 17: 615–628.
5. Branzei D, Foiani M (2009) The checkpoint response to replication stress. DNA
Repair (Amst) 8: 1038–1046.
6. Branzei D, Foiani M (2010) Maintaining genome stability at the replication fork.
Nat Rev Mol Cell Biol 11: 208–219.
7. Din S, Brill SJ, Fairman MP, Stillman B (1990) Cell-cycle-regulated
phosphorylation of DNA replication factor A from human and yeast cells.
Genes Dev 4: 968–977.
8. Zernik-Kobak M, Vasunia K, Connelly M, Anderson CW, Dixon K (1997) Sites
of UV-induced phosphorylation of the p34 subunit of replication protein A from
HeLa cells. J Biol Chem 272: 23896–23904.
9. Carty MP, Zernik-Kobak M, McGrath S, Dixon K (1994) UV light-induced
DNA synthesis arrest in HeLa cells is associated with changes in phosphorylation
of human single-stranded DNA-binding protein. EMBO J 13: 2114–2123.
10. Olson E, Nievera CJ, Klimovich V, Fanning E, Wu X (2006) RPA2 is a direct
downstream target for ATR to regulate the S-phase checkpoint. J Biol Chem
281: 39517–39533.
11. Manthey KC, Opiyo S, Glanzer JG, Dimitrova D, Elliott J, et al. (2007) NBS1
mediates ATR-dependent RPA hyperphosphorylation following replication-fork
stall and collapse. J Cell Sci 120: 4221–4229.
12. Shao RG, Cao CX, Zhang H, Kohn KW, Wold MS, et al. (1999) Replication-
mediated DNA damage by camptothecin induces phosphorylation of RPA by
DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes.
EMBO J 18: 1397–1406.
13. Pan ZQ, Amin AA, Gibbs E, Niu H, Hurwitz J (1994) Phosphorylation of the
p34 subunit of human single-stranded-DNA-binding protein in cyclin A-
activated G1 extracts is catalyzed by cdk-cyclin A complex and DNA-dependent
protein kinase. Proc Natl Acad Sci U S A 91: 8343–8347.
14. Brush GS, Anderson CW, Kelly TJ (1994) The DNA-activated protein kinase is
required for the phosphorylation of replication protein A during simian virus 40
DNA replication. Proc Natl Acad Sci U S A 91: 12520–12524.
15. Gately DP, Hittle JC, Chan GK, Yen TJ (1998) Characterization of ATM
expression, localization, and associated DNA-dependent protein kinase activity.
Mol Biol Cell 9: 2361–2374.
16. Morgan SE, Kastan MB (1997) Dissociation of radiation-induced phosphorylation of
replication protein A from the S-phase checkpoint. Cancer Res 57: 3386–3389.
17. Boubnov NV, Weaver DT (1995) scid cells are deficient in Ku and replication
protein A phosphorylation by the DNA-dependent protein kinase. Mol Cell Biol
15: 5700–5706.
18. Anantha RW, Sokolova E, Borowiec JA (2008) RPA phosphorylation facilitates
mitotic exit in response to mitotic DNA damage. Proc Natl Acad Sci U S A 105:
12903–12908.
19. Anantha RW, Vassin VM, Borowiec JA (2007) Sequential and synergistic
modification of human RPA stimulates chromosomal DNA repair. J Biol Chem
282: 35910–35923.
20. Motegi A, Liaw HJ, Lee KY, Roest HP, Maas A, et al. (2008) Polyubiquitination
of proliferating cell nuclear antigen by HLTF and SHPRH prevents genomic
instability from stalled replication forks. Proc Natl Acad Sci U S A 105:
12411–12416.
21. Solomon DA, Cardoso MC, Knudsen ES (2004) Dynamic targeting of the
replication machinery to sites of DNA damage. J Cell Biol 166: 455–463.
22. Stephan H, Concannon C, Kremmer E, Carty MP, Nasheuer HP (2009)
Ionizing radiation-dependent and independent phosphorylation of the 32-kDa
subunit of replication protein A during mitosis. Nucleic Acids Res 37:
6028–6041.
23. Niu H, Erdjument-Bromage H, Pan ZQ, Lee SH, Tempst P, et al. (1997)
Mapping of amino acid residues in the p34 subunit of human single-stranded
DNA-binding protein phosphorylated by DNA-dependent protein kinase and
Cdc2 kinase in vitro. J Biol Chem 272: 12634–12641.
24. Oakley GG, Patrick SM, Yao J, Carty MP, Turchi JJ, et al. (2003) RPA
phosphorylation in mitosis alters DNA binding and protein-protein interactions.
Biochemistry 42: 3255–3264.
25. Cheng X, Cheong N, Wang Y, Iliakis G (1996) Ionizing radiation-induced
phosphorylation of RPA p34 is deficient in ataxia telangiectasia and reduced in
aged normal fibroblasts. Radiother Oncol 39: 43–52.
26. Ruis BL, Fattah KR, Hendrickson EA (2008) The catalytic subunit of DNA-
dependent protein kinase regulates proliferation, telomere length, and genomic
stability in human somatic cells. Mol Cell Biol 28: 6182–6195.
27. Fernandez-Capetillo O, Chen HT, Celeste A, Ward I, Romanienko PJ, et al.
(2002) DNA damage-induced G2-M checkpoint activation by histone H2AX
and 53BP1. Nat Cell Biol 4: 993–997.
DNA-PK-Dependent RPA2 Phosphorylation
PLoS ONE | www.plosone.org 9 June 2011 | Volume 6 | Issue 6 | e2142428. Kannouche P, Broughton BC, Volker M, Hanaoka F, Mullenders LH, et al.
(2001) Domain structure, localization, and function of DNA polymerase eta,
defective in xeroderma pigmentosum variant cells. Genes Dev 15: 158–172.
29. San Filippo J, Sung P, Klein H (2008) Mechanism of eukaryotic homologous
recombination. Annu Rev Biochem 77: 229–257.
30. Block WD, Yu Y, Lees-Miller SP (2004) Phosphatidyl inositol 3-kinase-like
serine/threonine protein kinases (PIKKs) are required for DNA damage-
induced phosphorylation of the 32 kDa subunit of replication protein A at
threonine 21. Nucleic Acids Res 32: 997–1005.
31. Liu VF, Weaver DT (1993) The ionizing radiation-induced replication protein A
phosphorylation response differs between ataxia telangiectasia and normal
human cells. Mol Cell Biol 13: 7222–7231.
32. Wang H, Guan J, Perrault AR, Wang Y, Iliakis G (2001) Replication protein A2
phosphorylation after DNA damage by the coordinated action of ataxia
telangiectasia-mutated and DNA-dependent protein kinase. Cancer Res 61:
8554–8563.
33. Lee KY, Myung K (2008) PCNA modifications for regulation of post-replication
repair pathways. Mol Cells 26: 5–11.
34. Cruet-Hennequart S, Glynn MT, Murillo LS, Coyne S, Carty MP (2008)
Enhanced DNA-PK-mediated RPA2 hyperphosphorylation in DNA polymerase
eta-deficient human cells treated with cisplatin and oxaliplatin. DNA Repair
(Amst) 7: 582–596.
35. Lee DH, Pan Y, Kanner S, Sung P, Borowiec JA, et al. (2010) A PP4
phosphatase complex dephosphorylates RPA2 to facilitate DNA repair via
homologous recombination. Nat Struct Mol Biol 17: 365–372.
36. Nakanishi K, Yang YG, Pierce AJ, Taniguchi T, Digweed M, et al. (2005)
Human Fanconi anemia monoubiquitination pathway promotes homologous
DNA repair. Proc Natl Acad Sci U S A 102: 1110–1115.
DNA-PK-Dependent RPA2 Phosphorylation
PLoS ONE | www.plosone.org 10 June 2011 | Volume 6 | Issue 6 | e21424